Replies to post #9530 on Momenta Pharmaceuticals, Inc. (MNTA)

[iwfal]

I would suggest that the FDA will not repeat the kinds of disclosures it made in the Lovenox case in light of the Court’s ruling today

Why not - wouldn't they consider it part of their mandate to get as many generics approved as possible without violating laws?